Found 2,266 investors
CONTENTshift
United States
Dr. Stephen Farr is a Co-Founder and serves as Board Member, President, and Chief Executive Officer at Zogenix. He serves as Chairman of Cerebral Therapeutics. He is a Board member of Flow Pharma. He has been actively involved in the private and public financing of Zogenix, raising in excess of $250 million, and leading the company through an IPO in November 2010. He is responsible for Research and Development, Clinical Development, Regulatory Affairs, and Quality and Manufacturing Development functions. In this role, he has overseen the development and NDA approval of Sumavel DosePro, a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, the Phase 2/3 development of Zohydro, an extended-release oral formulation of single-entity hydrocodone, and in developing the early-stage pipeline of products based upon the DosePro technology. From 1995 to August 2006, he held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation, and he served most recently as Senior Vice President and Chief Scientific Officer. For 7 years, he led the inhaled insulin collaboration with Novo Nordisk and took the product from laboratory proof-of-concept to international Phase 3 clinical studies in Type 1 and Type 2 diabetes. In 2003, he played a key role in identifying and acquiring the DosePro technology and became technical director and executive sponsor for the development of sumatriptan DosePro at Aradigm Corporation. From 1986 to 1994, he was a tenured professor at the Welsh School of Pharmacy, Cardiff University, United Kingdom, concentrating in the areas of physical pharmacy and biopharmaceutics. He has widely published on advanced drug delivery and was made a Fellow of the American Association of Pharmaceutical Scientists in 1998. He is an Adjunct Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University and also serves on the board of ICVRx, a start-up, a clinical-stage company focused on new treatments for the treatment of medically refractory epilepsy. He is a Member of the Royal Pharmaceutical Society (registered pharmacist in the United Kingdom) and obtained his Ph.D. degree in Pharmaceutics from the University of Wales.
Individual/Angel
Cornelius Boersch
Switzerland
Dr. Cornelius Boersch serves as Chief Executive Officer & Director at Mountain & Co. I Acquisition. He is also the Co-Founder of Conny & Co. He serves as Board Member at Destinus. He serves as Angel Investor at Cornelius Boersch. He is also a Co-Founder and serves as Executive Chairman of the Board of Directors at Mountain Partners. He serves as Board Member at Lingoda. He also served as Advisor at Ideabox Ventures. He is also the Founder of ACG AG. After ACG he became a shareholder and investment partner of a large German-Swiss investment group. He received a Diploma from EBS University of Business of Law and a Degree from the University of Duisburg-Essen. He studied at the European Business School in Oestrich-Winkel and earned his Ph.D. from the University of Essen with a thesis on venture capital. He later also acted as honorary professor and held lectures at the University of Essen. He is an entrepreneur, business angel and founder of numerous technology companies. He initiated the Entrepreneurs Day at the Tegernsee 16 years ago and regularly holds speeches at universities or tech events all over the world. As a business angel, he has invested in more than 400 companies since 1995 and was voted "European Business Angel of the Year" in 2009. He is a European Investment Fund (EIF) - certified super angel, which means that the EIF matches his startup investments 1 to 1. For his activities he was named "Entrepreneur of the Year" in 2000. Conny has authored several books on topics ranging from digitalization to happiness and lifelong learning. His latest publication "Missed the future", which he wrote together. He became a bestseller and was translated into 8 languages. Politically, Conny acted as advisor to Dr. Guido Westerwelle, former president of the German Liberal Party, FDP, Vice-Chancellor and Foreign Minister of Germany from 2009 to 2012.
Individual/Angel
COSIMO Ventures
Dublin, Dublin, Ireland
COSIMO provides an active management approach for the growth acceleration of great technology companies across the globe.
Business Development
Financial Services
Health Care
Medical Device
Venture Capital
Venture Capital
CPI Enterprises Limited
United Kingdom
CPI acts as a catalyst bringing together academia, businesses, government, and investors to translate bright ideas and research into the marketplace. We do this by giving our customers access to the right experts, equipment, networks, funding, and more - connecting the dots for effective innovation. We are a leading independent technology innovation center and a founding member of the UK Government's High-Value Manufacturing Catapult. Established in 2004, our teams tirelessly apply their many years of experience to ensure that every great invention gets the best opportunity to become a successfully marketed product or process. We work with our partners across diverse markets in the UK and around the world, driving their innovations forward and helping them to reduce the risk and cost associated with product development.
Accelerator
Incubator
Craig Doriot
Appleton, Wisconsin, United States
CEO @ Pound Social | Missionaries in Business | Creating apps for social media as led by the Holy Spirit
Individual/Angel
Cresta Fund Management
United States
Founded in 2016, Cresta Fund Management is a middle-market focused infrastructure and private equity firm based in Dallas, Texas. The firm has a conservative, value-added approach to infrastructure investing. The firm seeks to invest in hard asset transportation, storage, and processing businesses primarily in the energy, chemicals and water sectors.
Infrastructure Fund
Cristi Anghel
Cluj-napoca, Cluj, Romania
CEO and founder of Bouncematch, a gamified app that allows squash players to find partners, book courts and improve their performance
Individual/Angel
Crosspring B.V.
United States
Ms. Lisa Hook serves as Board Member at Fidelity National Information Services. She serves as Board Member at Zayo Group. She serves as an Independent Member of the Board of Directors, Member of the Board's Risk & Audit Committee, Member of the Nomination & Compensation Committee and Member of the Investment Oversight Committee at Partners Group. She is also an angel investor. Ms. Hook served as President and Chief Executive Officer of Neustar, Inc. (NYSE: NSR) from October 2010 until July 2018 and as President and Chief Operating Officer from January 2008 until 2010. She joined the Neustar board in 2010 and continued to serve in that capacity until July 2019. Previously, she served as President and Chief Executive Officer of Sunrocket, Inc.; held several executive-level posts at America Online, Inc.; was a partner at Brera Capital Partners, a private equity firm focused on investing in media and telecommunications; managing director of Alpine Capital Group, LLC, an investment banking firm; held several executives and director positions at Time Warner, Inc.; and was a senior attorney at Viacom International, Inc. She serves on the boards of Philip Morris International (NYSE: PM), Unisys Corporation (NYSE: UIS), and Ping Identity Holding Corp. (NYSE: PING). She currently serves on the National Security Telecommunications Advisory Committee (NSTAC) to which she was appointed in 2012 by President Obama. In this role, she co-led the NSTAC Report to the President on Big Data Analytics. In recognition of her personal and professional achievements, The Dickinson School of Law and Penn State University honored her as a 2012 Penn State Alumni Fellow.
Individual/Angel
CubaSera Asset Management
United States
CubaSera Asset Management was a private equity firm that invested private capital in small and medium-sized enterprises located in Cuba. The firm took an active ownership approach by buying and building businesses that delivered financial return and implement ethical, social and environmental impacts to Cuba, its people, and the region as a whole. The firm was headquartered in New York, and maintained locations in Havana, Miami, and London.
Growth Capital
Cybernorth Ventures
Canada
Founded in 1995, Cybernorth Ventures is a venture capital firm based in Toronto, Canada. The firm seeks to invest in seed-stage technology companies focused on sectors such as social networks, big data, healthcare applications, cloud computing, nano-technology, security applications, digital media, financial technology, service application, clean and environmental technology, and mobile computing within the Toronto-Waterloo region.
Venture Capital
Cypress Partners
United States
Cypress Partners was a private equity firm specialized in operationally oriented buyouts of established manufacturing, value-added distribution, applied technology and financial services companies.
Private Equity Firm
Dana Wagner
Sweden
Mr. Ulf Landegren is the Founder and serves as Co-Owner of Olink Proteomics. He is also a Co-Founder and serves as Board Member at Navinci Diagnostics. He is an internationally recognized scientific leader in molecular detection and amplification technologies, with an established network in the scientific and biotech business communities. Prof. Landegren has authored more than 100 peer-reviewed articles and is the designated inventor of more than 20 patents and patent applications. He serves as a Board Member at Q-linea. He is the author of more than 220 publications and co-inventor of more than 45 patents. Professor Landegren is the cofounder of several companies, HaloGenomics AB, and Q-Linea AB. He is a member of the Swedish Royal Academy of Sciences and the European Molecular Biology Organization, and he has been or is currently a member of scientific advisory boards for more than 10 companies.
Individual/Angel
Dan Boneh
United States
Mr. Andrew Laing served as Deputy Chief Executive Officer & Member of Advisory Council at Aberdeen Asset Management. Andrew graduated from Aberdeen University with a MA in Politics and International Relations and a degree in Law. Andrew commenced his professional career as a Commercial Lawyer in 1977 before moving to the financial industry to manage venture capital funds. He then joined the Group in 1986 with responsibility for private equity investment. Andrew was subsequently appointed chief operating officer, originally joining the Board in 1987 and was appointed deputy chief executive in 2008. Andrew is a director of a number of Group subsidiaries and has been a non-executive director of a variety of external companies.
Individual/Angel
Dan Călugăreanu
United States
Dr. Lynwood Swanson was a Founder and served as and Consultant at FEI. He is the Founder and serves as the Consultant at FEI. He is the Board Member at MJ Murdock Charitable Trust. Lyn was named to the Board August 25, 1987, to succeed founding Trustee Paul Boley. He has a wide background in research and in academic teaching and administration. From 1968-1973 he was academic dean at Linfield College. From 1973-1987 he was associate professor, then professor, of applied physics at Oregon Graduate Institute of Science & Technology in Beaverton, Oregon. From 1987-2002 he was CEO and chairman of FEI Company in Hillsboro, OR, which he founded in 1971. Lyn is the recipient of many honors, including the Howard Vollum award; the Outstanding Scientific Contribution Award as Scientist of the Year; and the NASA New Technology Award. He holds twelve patents and has written extensively on technical subjects. Lyn received his Ph.D. in physical chemistry from University of California/Davis in 1959 and his B.Sc. in physics and chemistry from University of the Pacific in 1956.
Individual/Angel
Dan Ellis
United States
Ms. Robin Ferracone serves as Board Member, Chairwoman of Compensation Committee and Member of Nominating and Corporate Governance Committee at Trupanion. Ms. Robin Ferracone serves as Founding Partner, Chairman & Chief Executive Officer at Farient Advisors. She is a member of the Committee of 200, Women Corporate Directors, YPO-Gold, WorldatWork, and NACD. She provides compensation and performance advisory services to public and private companies. From March 2005 to March 2007, she was President of the Human Capital business of Mercer, a business which includes talent and compensation consulting, software and data services globally. With over 30 years of consulting experience, she has advised clients in the areas of business and talent strategies, executive compensation, organization, value management and performance measurement. Ms. Ferracone received an M.B.A. from the Harvard Business School, where she was a Baker Scholar and a B.A. summa cum laude in Management Science and Economics from Duke University, where she was elected to Phi Beta Kappa.
Individual/Angel
Dan Guo
United States
Mr. Mike Jones served as Chief Executive Officer at Simplebills. After Mike's son and his roommate founded SimpleBills, a Roommate Utility Billing service, he became an investor, left the software industry to move to Waco, TX from Houston and assumed responsibility as the CEO. Prior to SimpleBills, Mike spent 30+ years in the business application software industry for companies such as SAP, Oracle, JD Edwards, Infinium and IPNet. Mike is a graduate from the University of Houston with a BBA in Marketing.
Individual/Angel
Dan Hesse
Kansas City, Missouri, United States
Dan Hesse was the CEO of Sprint Nextel from December 2007 to August 2014. Prior to his appointment as Sprint CEO, Hesse was the Chairman...
Individual/Angel
Daniel Applewhite
Cambridge, Massachusetts
Investor @ Dorm Room Fund
Digital Health
E-commerce
Education
Enterprise
FinTech
Future of Work
Gig Economy
Health IT
SaaS
Sales & CRM
Daniel Cowell
Italy
Mr. Stefano Pessina serves as Executive Chairman of the Board of Directors at Walgreens Boots Alliance. Prior to this, he was Executive Chairman of Alliance Boots since July 2007. Pessina previously served as Alliance Boots Executive Deputy Chairman. Prior to the merger of Alliance UniChem and Boots plc, Pessina was Executive Deputy Chairman of Alliance UniChem, previously having been its Chief Executive for three years through December 2004. Pessina was appointed to the Alliance UniChem Board in 1997 when UniChem merged with Alliance Santé, the Franco-Italian pharmaceutical wholesale group which he established in Italy in 1977. Pessina also serves on the Board of Directors of Galenica AG, a publicly-traded Swiss healthcare group, and a number of private companies.
Individual/Angel
Daniel Kaufman
Canada
Dr. Andrew Csinger served as Chief Conspiracy Officer and Interim Chief Technology Officer at FusionPipe. Dr. Csinger served as Director at A2B Fiber. He is Entrepreneur in Residence and Adjunct Professor in the Cognitive Systems Group at the University of British Columbia. He is an advisor or director to several start-up companies and is on the Board of Advisors of ISSNet, a research network focused on computer and network security funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). He is also a founding member of the Steering Committee for the Vancouver Institute of Visual Analytics. Dr. Csinger was Executive Vice-President of Product Strategy and Development at Dategrity Corp., a spin-out from the Votehere Corporation. He was Senior Vice-President and Chief Information Officer of Group Telecom from 1998 to 2002. In 1998, he developed and operated the first Public Key Infrastructure (PKI) Certification Authority and Repository to be licensed under Washington State Digital Signature legislation. This seminal work influenced the later adoption of federal U.S. law (the Electronic Signatures in Global and National Commerce Act of 2000, or "E-Sign Act"), and was an early model for the adoption by other states of the Uniform Electronic Transactions Act (UETA). In 1996, he founded Xcert Software Inc. (acquired by RSA Technologies), a technology leader in the emerging business of PKI. Dr. Csinger was a mentor of the SFU Technology Business Mentorship Program and has been both mentor and reviewer for the New Ventures BC business plan competition since 2007. He was an NSERC Post-Doctoral Fellow at Simon Fraser University, and a visiting scholar at the German Center for Artificial Intelligence in Saarbrucken. Dr. Csinger's work on artificial intelligence techniques has appeared in journals and conferences around the world. He holds several patents in Internet security, biometrics and related areas. Dr. Csinger holds a Ph.D. and M.Sc. in Computer Science from the University of British Columbia and a Bachelor's degree in Electrical Engineering from McGill University.
Individual/Angel
Showing 861 to
880 of
2,266 results